CClinicalTrials.gg
CompletedNCT07377851CAII-BASKETUpdated Jan 30, 2026

Carbonic Anhydrase II Responses to Basketball-Specific High-Intensity Interval Training

An interventional study of Basketball-Specific High-Intensity Interval Training in Metabolic Adaptation to High-Intensity Interval Training, sponsored by Karamanoğlu Mehmetbey University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-30.

Sponsored by Karamanoğlu Mehmetbey University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Not applicable
Ages
18 Years to 30 Years
Sex
Male
01

Study summary

This study aims to examine whether erythrocyte carbonic anhydrase II can be used as a biological marker of metabolic adaptation to basketball-specific high-intensity interval training. Carbonic anhydrase II is an enzyme involved in acid-base balance and carbon dioxide transport, and it may reflect physiological adaptations to intense exercise.

Healthy basketball players participated in a structured high-intensity interval training program designed to reflect the physical demands of basketball. Blood samples and performance-related measurements were collected before and after the training period to evaluate changes in erythrocyte carbonic anhydrase II levels and related metabolic responses.

The findings of this study are expected to improve the understanding of exercise-induced metabolic adaptations and to explore the potential use of erythrocyte carbonic anhydrase II as a practical biomarker for monitoring training responses in basketball players.

Read the detailed description

This study was designed to investigate erythrocyte carbonic anhydrase II as a potential biomarker of metabolic adaptation to basketball-specific high-intensity interval training. Carbonic anhydrase II plays a key role in acid-base regulation and carbon dioxide transport, which are critical physiological processes during repeated high-intensity exercise.

Participants were healthy basketball players who completed a structured high-intensity interval training program reflecting the intermittent and high-demand nature of basketball activity. The training protocol consisted of repeated bouts of intense exercise interspersed with short recovery periods, consistent with established basketball-specific conditioning practices.

Blood samples were obtained at predefined time points to assess erythrocyte carbonic anhydrase II levels. These biochemical measurements were evaluated alongside selected performance and physiological indicators to characterize training-induced metabolic adaptations. All assessments were conducted under standardized conditions to minimize variability related to diet, hydration, and recent physical activity.

The study followed an observational pre-post design without clinical intervention beyond the prescribed training program. No experimental drugs or medical devices were used. Safety monitoring was conducted throughout the study period, and no serious adverse events were anticipated given the low-risk nature of the exercise protocol and the healthy status of the participants.

This study seeks to contribute to the growing body of research on exercise-related biomarkers by examining whether erythrocyte carbonic anhydrase II may provide practical insight into metabolic adaptation to sport-specific high-intensity training.

02

Conditions studied

  • Metabolic Adaptation to High-Intensity Interval Training

Keywords

  • Carbonic Anhydrase II
  • Exercise Physiology
  • Metabolic Adaptation
  • High-Intensity Interval Training
  • Basketball Training
03

In context

Lead sponsor

Karamanoğlu Mehmetbey University is the lead sponsor of 65 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

Healthy male and female basketball players aged 18 years or older

Actively participating in regular basketball training at the time of the study

Free from known cardiovascular, metabolic, or respiratory diseases

No musculoskeletal injury that could limit participation in high-intensity exercise

Willingness to participate in a basketball-specific high-intensity interval training program

Ability to provide written informed consent

Exclusion criteria

Exclusion Criteria:

Presence of any diagnosed cardiovascular, metabolic, or respiratory disease

Use of medications or supplements known to affect metabolic or acid-base balance

Acute or chronic musculoskeletal injury within the previous three months

Participation in another structured training or research intervention during the study period

Failure to comply with the training protocol or assessment procedures

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Basketball-Specific High-Intensity Interval Training

    Participants completed a basketball-specific high-intensity interval training program designed to induce metabolic adaptations. All participants were assigned to this single intervention arm and completed the same training protocol.

    Behavioral: Basketball-Specific High-Intensity Interval Training

Interventions

  • BehavioralBasketball-Specific High-Intensity Interval Training

    A structured basketball-specific high-intensity interval training program consisting of repeated bouts of intense exercise interspersed with short recovery periods, designed to induce metabolic adaptations.

06

What researchers measure

Primary outcomes

  1. Change in Erythrocyte Carbonic Anhydrase II Levels

    The primary outcome is the change in erythrocyte carbonic anhydrase II levels measured before and after the basketball-specific high-intensity interval training program. Erythrocyte carbonic anhydrase II was assessed from blood samples as an indicator of metabolic adaptation to high-intensity exercise.

    Time frame: Baseline( week 0) and post training (week 8)

07

Study locations

1 site
  • Karamanoğlu Mehmetbey University, Faculty of Sport Sciences
    Karaman, Karaman 70200, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07377851
Lead sponsor
Karamanoğlu Mehmetbey University
Responsible party
Recep Soslu (Associate Professor, Karamanoğlu Mehmetbey University) — Principal investigator
First posted
Jan 30, 2026
Start date
Nov 1, 2025
Primary completion
Jan 10, 2026
Completion
Jan 15, 2026
Last update
Jan 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion